Also trades as: ICCM.TA (TLV) · $vol 0M
ICCM NASDAQ
IceCure Medical Ltd
1W: -9.2%
1M: -30.5%
3M: -65.9%
YTD: -91.7%
1Y: -94.7%
3Y: -91.3%
5Y: -99.5%
$1.57
-0.12 (-7.10%)
Weekly Expected Move ±7.5%
$1
$1
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$15M
-16.0% ▼
Capital Expenditures
$36K
+49.3% ▲
5Y CAGR: -30.6%
Free Cash Flow
-$15M
-15.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1M
+144.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$10M | -$17M | -$15M | -$15M | -$15M |
| Depreciation & Amort. | $127K | $248K | $323K | $332K | $295K |
| Stock-Based Comp. | $316K | $2M | $1M | $869K | $0 |
| Change in Working Capital | -$3M | $214K | $523K | $2M | -$1M |
| Other Non-Cash Items | $5K | $359K | -$25K | $39K | $1M |
| Operating Cash Flow | -$13M | -$14M | -$13M | -$13M | -$15M |
| — Investing Activities — | |||||
| Capital Expenditures | -$533K | -$891K | -$480K | -$71K | -$36K |
| Acquisitions (Net) | -$4M | $0 | $0 | $0 | $0 |
| Investment Purchases | -$308K | $0 | $0 | -$1M | -$5M |
| Investment Sales | $5M | $0 | $0 | $2M | $5M |
| Other Investing | $4M | $0 | -$233K | -$12K | $0 |
| Investing Cash Flow | $4M | -$891K | -$713K | $446K | -$36K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $337K | $2K | $0 | $0 | $0 |
| Financing Cash Flow | $31M | $14M | $83K | $9M | $16M |
| Net Change in Cash | $22M | -$2M | -$13M | -$3M | $1M |
| Cash End of Period | $26M | $24M | $11M | $8M | $9M |
| Free Cash Flow | -$13M | -$15M | -$13M | -$13M | -$15M |